Simultaneous Multi-Vessel Subacute Stent Thromboses in Zotarolimus-Eluting Stents.
10.4070/kcj.2010.40.5.243
- Author:
Yong Hyun KIM
1
;
Soon Yong SUH
;
Seong Hwan KIM
;
Sang Yup LIM
;
Seung Young ROH
;
Ji Bak KIM
;
Woo Hyuk SONG
;
Jeong Cheon AHN
Author Information
1. Cardiovascular Center, Korea University Ansan Hospital, Ansan, Korea. hhansin@korea.ac.kr
- Publication Type:Case Report
- Keywords:
Zotarolimus;
Drug-eluting stents;
Stents;
Thrombosis
- MeSH:
Arteries;
Coronary Vessels;
Drug-Eluting Stents;
Europe;
Incidence;
Percutaneous Coronary Intervention;
Sirolimus;
Stents;
Thrombosis
- From:Korean Circulation Journal
2010;40(5):243-246
- CountryRepublic of Korea
- Language:English
-
Abstract:
Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal stent thromboses related to this new drug eluting stent (DES) have been reported. We experienced a case of simultaneous subacute ZES thromboses, 6 days after stent implantations in the proximal left anterior descending artery and the proximal right coronary artery (RCA).
